A recent study suggests that semaglutide, typically used for Type 2 diabetes, may significantly reduce the risk of opioid overdoses in patients with opioid use disorder, according to research published Sept. 25 by JAMA Network.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
